What Should Hims & Hers Health, Inc. Investors Know After 14.73% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline

Lawsuit alleges Hims & Hers Health, Inc. made misleading statements to investors from August 4, 2025 to July 29, 2026; lead plaintiff motions are due November 2, 2026

LOS ANGELES, Oct. 30, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz today announced a class action lawsuit against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors who acquired the Company's securities from August 4, 2025 to July 29, 2026. Filed on September 1, 2026, the case is Velanki v. Hims & Hers Health, Inc., et al., U.S. District Court for the Northern District of California, Case No. 3:26-cv-09313.

If you lost money on Hims & Hers Health, Inc. securities, submit your Hims & Hers Health, Inc. loss information by November 2, 2026 to learn about participating in the lawsuit.

Hims & Hers Health, Inc. class action timeline

• Class period begins: August 4, 2025
• Class period ends: July 29, 2026
• Complaint filed: September 1, 2026
• Lead plaintiff motion deadline: November 2, 2026

What happened?

On July 29, 2026, the Federal Trade Commission, joined by the State of Utah and Los Angeles County (representing California), filed a federal complaint against Hims & Hers Health in the U.S. District Court for the Northern District of California, alleging deceptive and unlawful privacy practices — including sharing sensitive user health data with third-party advertisers Meta Platforms (Facebook) and Snap via embedded tracking pixels and customer list matching despite marketing emphasizing strict privacy — as well as deceptive billing and subscription-cancellation practices.

On this news, shares of Hims & Hers fell $4.32, or 14.73%, to close at $25.00 per share on July 29, 2026, thereby injuring investors.

What is the Hims & Hers Health, Inc. lawsuit about?

The Hims & Hers Health, Inc. securities lawsuit alleges that, between August 4, 2025 and July 29, 2026, defendants made materially false and/or misleading statements and failed to disclose material adverse facts about Hims & Hers Health, Inc.'s business, operations, and prospects. Specifically, the complaint alleges defendants failed to disclose that: (1) the Company shared consumers' health information with third-party advertising platforms; (2) the Company charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find a treatment that is "right for them"; (3) the foregoing conduct subjected the Company to regulatory scrutiny; (4) as a result of the foregoing, the Company was reasonably likely to incur fees and penalties; and (5) as a result, defendants' positive statements about Hims & Hers Health, Inc.'s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

"According to the complaint filed against Hims & Hers Health, Inc., the Company, among other things, did not disclose that the Company shared consumers' health information with third-party advertising platforms. The November 2, 2026 deadline is a key date for Hims & Hers Health, Inc. investors who want a voice in how this case moves forward," said Frank R. Cruz of The Law Offices of Frank R. Cruz.

What should Hims & Hers Health, Inc. investors do now?

The Law Offices of Frank R. Cruz can help Hims & Hers Health, Inc. investors evaluate potential claims to recover their losses.

Investors who want to serve as lead plaintiff in the Hims & Hers Health, Inc. class action must file a motion with the Court by November 2, 2026. For more information, visit the Hims & Hers Health, Inc. case page, email [email protected], or call 310-914-5007.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

Investors may retain counsel of their choice. Hims & Hers Health, Inc. investors who bought during the class period may also take no action and remain absent class members. No class has been certified yet in the Hims & Hers Health, Inc. case.

Questions and answers about the Hims & Hers Health, Inc. lawsuit

Who is eligible? Investors who bought Hims & Hers Health, Inc. securities between August 4, 2025 and July 29, 2026 and lost money may be class members, and may seek lead plaintiff appointment by November 2, 2026.

What does a lead plaintiff do? The lead plaintiff is appointed by the court to represent all class members and direct the Hims & Hers Health, Inc. class action.

Must I be lead plaintiff to share in a recovery? No, Hims & Hers Health, Inc. investors can take no action and remain absent class members.

How are attorneys' fees handled? The Law Offices of Frank R. Cruz works on contingency, so Hims & Hers Health, Inc. investors pay no attorneys' fees up front. Any attorneys' fees and litigation expenses come only from a recovery, if there is one, and require court approval.

About The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz investigates and prosecutes securities fraud and corporate malfeasance class actions. With nearly 20 years of litigation experience, the firm focuses on complex securities class actions and gives each client personal, one-on-one attention throughout the legal process.

Prior results do not guarantee a similar outcome.

Related links

• Hims & Hers Health, Inc. case page, The Law Offices of Frank R. Cruz
• Complaint: Velanki v. Hims & Hers Health, Inc., et al., U.S. District Court for the Northern District of California
• FTC complaint
• Hims & Hers Health, Inc. SEC filings index, EDGAR
• The Law Offices of Frank R. Cruz

Follow The Law Offices of Frank R. Cruz for updates on Twitter: twitter.com/FRC_LAW

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

SOURCE The Law Offices of Frank R. Cruz, Los Angeles